Search

everythinglearnresearchcommunity

for

Search:↓

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Vitamin D receptor may help protect against UV-induced skin cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Terbinafine and itraconazole are more effective against Microsporum canis than fluconazole and griseofulvin.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Itraconazole was effective in treating unusual M. canis infections in only one of two HIV-infected men.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Suppressing certain hormones might help prevent prostate cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

Mutations in certain receptors can cause diseases and offer new treatment options.